Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Starbucks Stock Catches a Luckin Break, But Its Future Is Bleak

By Dana Blankenhorn, InvestorPlace Contributor

Starbucks may have to shut down stores completely through the coronavirus outbreak, and will need new capital to save SBUX stock.

Any COVID-19 Vaccine Upside Already Is Built Into MRNA Stock

By Dana Blankenhorn, InvestorPlace Contributor

If you buy Moderna today, you're betting on the mRNA technology behind it, not its coronavirus vaccine.

CVS Stock Is a Winner Beyond the Pandemic

By Dana Blankenhorn, InvestorPlace Contributor

CVS Health was already moving toward managed care before the coronavirus, making CVS stock a long-term winner here.

Can a Cruise-less Carnival Survive the Storm?

By Dana Blankenhorn, InvestorPlace Contributor

Executive chairman Mickey Arison has the cash and the contacts to save Carnival. But current common CCL stock shareholders may not be invited to the party.

Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap

By Dana Blankenhorn, InvestorPlace Contributor

Gilead Sciences rose to prominence with its hepatitis C drug. Now GILD stock is soaring on hopes for a coronavirus treatment.

Micron Stock Offers Investors Hope in a Turbulent Market

By Dana Blankenhorn, InvestorPlace Contributor

Micron's better-than-expected quarter and chip potential shows that MU stock has serious room to rebound after the coronavirus.

Best ETFs of 2020: The Global X Cloud Computing Fund Should Be a Winner

By Dana Blankenhorn, InvestorPlace Contributor

The CLOU ETF could be among the best ETFs to buy this year since it invests in cloud applications, which have seen accelerating growth since the coronavirus pandemic began.

Cloud Stocks Look More Valuable as the Coronavirus Spreads

By Dana Blankenhorn, InvestorPlace Contributor

Some cloud stocks are stronger than others, but all are proving vital as more and more Americans spend time at home.

Why Exxon Mobil Stock Resembles a Tobacco Play Now

By Dana Blankenhorn, InvestorPlace Contributor

Exxon Mobil is due to spend $14.27 billion this year on its dividend, but the coronavirus and oil war make XOM stock's 10% yield questionable.

Clorox Stock Is Taking a Wild Ride on the Coronavirus Catalyst

By Dana Blankenhorn, InvestorPlace Contributor

The success of CLX stock over the last month illustrates the value of diversification, keeping defensive and growth names in your portfolio.

Load More